Literature DB >> 16127596

[IV Guideline for ambulatory blood pressure monitoring. II Guideline for home blood pressure monitoring. IV ABPM/II HBPM].

Alexandre Alessi, Andréa A Brandão, Angela Pierin, Audes Magalhães Feitosa, Carlos Alberto Machado, Cláudia Lúcia de Moraes Forjaz, Cristina S Atie, Dante Marcelo Artigas Giorgi, Décio Mion, Eduardo Cantoni Rosa, Fernando Nobre, Giovânio Vieira Silva, Hilton Chaves, Istênio José Fernandes Pascoal, Jorge Ilha Guimarães, José Luis Santello, José Márcio Ribeiro, José Nery Praxedes, Kátia Coelho Ortega, Lílian Soares da Costa, Luis Aparecido Bortolotto, Marco Antonio Mota Gomes, Maurício Wajngarten, Miguel Gus, Osvaldo Kohlmann, Paulo César Veiga Jardim, Tufik José Magalhães Geleilete, Vera Koch.   

Abstract

Mesh:

Year:  2005        PMID: 16127596     DOI: 10.1590/S0066-782X2005002100001

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  12 in total

Review 1.  Arm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelines.

Authors:  James B Byrd; Robert D Brook
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-01-28       Impact factor: 3.738

2.  First Thomas Pickering memorial lecture*: ambulatory blood pressure measurement is essential for the management of hypertension.

Authors:  Eoin O'Brien
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-13       Impact factor: 3.738

3.  Burnt sugarcane harvesting - cardiovascular effects on a group of healthy workers, Brazil.

Authors:  Cristiane Maria Galvão Barbosa; Mário Terra-Filho; André Luis Pereira de Albuquerque; Dante Di Giorgi; Cesar Grupi; Carlos Eduardo Negrão; Maria Urbana Pinto Brandão Rondon; Daniel Godoy Martinez; Tânia Marcourakis; Fabiana Almeida dos Santos; Alfésio Luís Ferreira Braga; Dirce Maria Trevisan Zanetta; Ubiratan de Paula Santos
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

4.  Effects of aerobic exercise intensity on 24-h ambulatory blood pressure in individuals with type 2 diabetes and prehypertension.

Authors:  Pâmella Karoline de Morais; Marcelo Magalhães Sales; Jeeser Alves de Almeida; Daisy Motta-Santos; Caio Victor de Sousa; Herbert Gustavo Simões
Journal:  J Phys Ther Sci       Date:  2015-01-09

Review 5.  Ambulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows.

Authors:  Fernando Nobre; Décio Mion Junior
Journal:  Arq Bras Cardiol       Date:  2016-05-06       Impact factor: 2.000

6.  Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure.

Authors:  Arise G S Galil; Hélady S Pinheiro; Alfredo Chaoubah; Darcília M N Costa; Marcus G Bastos
Journal:  BMC Nephrol       Date:  2009-10-21       Impact factor: 2.388

7.  Aldosterone excess or escape: Treating resistant hypertension.

Authors:  Samira Ubaid-Girioli; Leoní Adriana de Souza; Juan Carlos Yugar-Toledo; Luiz Cláudio Martins; Sílvia Ferreira-Melo; Otávio Rizzi Coelho; Cristina Sierra; Antonio Coca; Eduardo Pimenta; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-05       Impact factor: 3.738

8.  Evaluation of Criteria to Detect Masked Hypertension.

Authors:  John N Booth; Paul Muntner; Keith M Diaz; Anthony J Viera; Natalie A Bello; Joseph E Schwartz; Daichi Shimbo
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-29       Impact factor: 3.738

9.  Acute aerobic exercise reduces 24-h ambulatory blood pressure levels in long-term-treated hypertensive patients.

Authors:  Emmanuel G Ciolac; Guilherme V Guimarães; Veridiana M D'Avila; Luiz A Bortolotto; Egídio L Doria; Edimar A Bocchi
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

10.  Exaggerated blood pressure response during the exercise treadmill test as a risk factor for hypertension.

Authors:  S G Lima; M F P M Albuquerque; J R M Oliveira; C F J Ayres; J E G Cunha; D F Oliveira; R R Lemos; M B R Souza; O Barbosa e Silva
Journal:  Braz J Med Biol Res       Date:  2013-04-19       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.